"Sox-2 inhibitors," a class of chemical compounds, are a group of small molecules designed to target and inhibit the activity of the transcription factor known as Sox-2 (Sex-determining region Y-box 2). Sox-2 is a critical regulator of embryonic stem cell pluripotency and plays a pivotal role in maintaining the undifferentiated state of stem cells. These inhibitors have garnered significant attention in the field of molecular biology and regenerative medicine due to their ability to modulate cellular differentiation processes and provide insights into the fundamental mechanisms governing cell fate determination.
The mechanism of action of Sox-2 inhibitors primarily involves interfering with the transcriptional activity of Sox-2. Sox-2 is a transcription factor that binds to specific DNA sequences, known as Sox-2 response elements, in the promoter regions of target genes, thereby regulating their expression. Sox-2 inhibitors work by disrupting the binding of Sox-2 to these target genes, effectively downregulating their expression. This interference can be achieved through various means, such as directly inhibiting Sox-2 protein function or indirectly modulating upstream signaling pathways that regulate Sox-2 expression. For instance, some Sox-2 inhibitors target key signaling pathways like TGF-beta, BMP, or Wnt, which are known to regulate Sox-2 expression. Others may function as epigenetic modulators, altering the chromatin structure or histone modifications at Sox-2 gene loci, thereby controlling its transcription. These chemical compounds have proven valuable in experimental settings, allowing researchers to finely tune cellular differentiation processes, explore developmental biology, and advance our understanding of stem cell biology. The development and refinement of Sox-2 inhibitors continue to be a focal point in the quest to unravel the intricacies of cellular differentiation and its applications in various fields of biology and medicine.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
ALK5 Inhibitor II | 446859-33-2 | sc-221234 sc-221234A sc-221234B sc-221234C sc-221234D sc-221234E sc-221234F | 1 mg 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $75.00 $150.00 $215.00 $650.00 $1224.00 $4296.00 $7818.00 | 8 | |
ALK5 Inhibitor II, also called RepSox, inhibits SOX-2 by targeting TGF-beta signaling pathway. It modulates Smad2/3 phosphorylation, reducing SOX-2 expression. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 free base | sc-202651 | 5 mg | $148.00 | 4 | |
BIX-01294 is a histone methyltransferase inhibitor that indirectly suppresses SOX-2 expression by modulating epigenetic regulation. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
SB431542 is a TGF-beta receptor inhibitor that downregulates SOX-2 by inhibiting the TGF-beta signaling pathway. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $153.00 $520.00 | 4 | |
Chir99021 promotes neural differentiation by inhibiting GSK-3, which leads to reduced SOX-2 expression. | ||||||
4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | 1062368-24-4 | sc-476297 | 5 mg | $240.00 | ||
LDN-193189 is a BMP type I receptor inhibitor, reducing SOX-2 through the BMP signaling pathway. | ||||||
JIB 04 | 199596-05-9 | sc-397040 | 20 mg | $177.00 | ||
JIB-04 is a Jumonji histone demethylase inhibitor that indirectly suppresses SOX-2 expression via epigenetic regulation. | ||||||
INK 128 | 1224844-38-5 | sc-364511 sc-364511A | 5 mg 50 mg | $315.00 $1799.00 | ||
INK128 targets mTOR, reducing SOX-2 expression through the mTOR signaling pathway. | ||||||
Salinomycin | 53003-10-4 | sc-253530 sc-253530C sc-253530A sc-253530B | 5 mg 10 mg 25 mg 100 mg | $159.00 $236.00 $398.00 $465.00 | 1 | |
Salinomycin is a potassium ionophore that depletes cancer stem cells by decreasing SOX-2 expression. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $58.00 $170.00 | 15 | |
Nifedipine indirectly inhibits SOX-2 by blocking calcium channels and affecting calcium-dependent signaling pathways. | ||||||